sinc
world
health
organ
declar
global
outbreak
sever
acut
respiratori
syndrom
sar
contain
juli
new
case
period
reemerg
asia
situat
place
hospit
health
offici
worldwid
heighten
alert
futur
outbreak
rapidli
accur
distinguish
sar
common
febril
respiratori
ill
fri
could
difficult
construct
decisionanalysi
model
identifi
effici
strategi
manag
undifferenti
fri
within
hypothet
sar
outbreak
new
york
citi
season
respiratori
infect
establish
reliabl
epidemiolog
link
possibl
societ
cost
would
exceed
billion
per
month
sar
test
exist
polymeras
chain
reaction
assay
would
harm
public
health
econom
consequ
sar
made
circul
fri
increas
influenza
vaccin
rate
among
gener
popul
onset
respiratori
season
would
save
money
live
n
juli
world
health
organ
declar
human
chain
transmiss
sever
acut
respiratori
syndrom
sar
end
sinc
new
case
sar
resurfac
asia
includ
sever
absenc
laboratori
exposur
reemerg
sarsassoci
coronaviru
sarscov
spark
intern
concern
prompt
heighten
surveil
hospit
health
offici
worldwid
concern
amplifi
fear
futur
sar
outbreak
could
coincid
respiratori
infect
season
influenza
infect
febril
respiratori
ill
fri
develop
larg
segment
popul
current
sar
casedefinit
caseexclus
criteria
encompass
clinic
epidemiolog
laboratori
featur
time
establish
epidemiolog
link
sar
case
lost
futur
outbreak
frontlin
healthcar
provid
would
forc
reli
clinic
sign
symptom
diagnost
test
confirm
exclud
infect
sarscov
unfortun
sign
symptom
sar
nonspecif
use
reliabl
differenti
sar
fri
moreov
exist
serolog
test
sarscov
definit
exclud
infect
least
week
elaps
onset
symptom
thu
role
earli
clinic
decis
make
although
revers
transcriptasepolymeras
chain
reaction
rtpcr
assay
use
detect
sarscov
provid
test
result
within
matter
hour
suboptim
sensit
make
inadequ
rule
sar
furthermor
sinc
sar
infect
would
like
make
minut
fraction
fri
circul
among
gener
popul
pretest
probabl
thu
posit
predict
valu
rtpcr
test
would
extrem
low
even
futur
gener
assay
better
test
sensit
specif
emerg
sarscov
china
coincid
respiratori
ill
season
suggest
viru
may
resurfac
winter
month
like
mani
respiratori
pathogen
season
pattern
recur
rapidli
accur
differenti
sar
infect
fri
would
becom
critic
compon
futur
outbreak
contain
effort
distinct
also
continu
import
issu
among
travel
fri
develop
return
sarsaffect
area
howev
exist
diagnost
limit
place
frontlin
healthcar
practition
precari
posit
sinc
clinic
decis
potenti
danger
consequ
must
made
face
uncertainti
recogn
limit
recent
call
develop
evidencebas
clinic
algorithm
help
address
diagnost
dilemma
hypothet
cohort
compris
resid
new
york
citi
enter
decisionanalysi
model
model
premis
sar
outbreak
respiratori
season
persontoperson
transmiss
sar
document
epidemiolog
link
case
poorli
defin
outbreak
design
consist
size
durat
toronto
outbreak
analyt
horizon
analysi
defin
expect
lifetim
person
live
new
york
citi
respiratori
ill
season
fri
defin
herein
nonspecif
infect
caus
pathogen
sarscov
microbiolog
origin
determin
basi
clinic
ground
alon
model
design
identifi
effect
costeffect
use
societ
resourc
manag
fri
undetermin
origin
sar
outbreak
analysi
conduct
adher
refer
case
scenario
defin
panel
costeffect
health
medicin
relev
cost
benefit
consid
societ
perspect
new
york
citi
includ
relat
secondari
transmiss
sar
sinc
cost
chang
healthrel
qualiti
life
analysi
limit
singl
respiratori
season
discount
perform
paramet
howev
futur
year
life
lost
due
prematur
death
infect
discount
annual
rate
decisionanalysi
model
construct
use
data
treeag
softwar
williamstown
usa
examin
compet
strategi
context
sar
outbreak
coincid
respiratori
season
home
isol
person
fri
undetermin
origin
pend
fever
symptom
resolut
least
hour
outpati
diagnost
test
fri
ascertain
microbiolog
diagnosi
subsequ
testdriven
manag
third
complementari
strategi
entail
mass
influenza
vaccin
among
gener
popul
onset
respiratori
season
consid
conjunct
compet
strategi
primari
assumpt
model
follow
epidemiolog
linkag
sar
case
well
defin
sar
reliabl
distinguish
fri
clinic
ground
alon
current
sar
test
definit
rule
infect
earli
cours
ill
public
nonadher
home
isol
guidelin
sar
outbreak
would
neglig
posit
sar
rtpcr
test
requir
isol
precaut
pend
confirm
diagnosi
patient
confirm
sar
case
manag
inpati
pend
resolut
clinic
ill
patient
confirm
sar
case
requir
isol
precaut
day
resolut
ill
person
fri
undetermin
origin
must
afebril
symptomfre
hour
return
work
neg
sar
rtpcr
test
alon
influenc
sar
isol
precaut
neg
sar
rtpcr
test
result
combin
posit
test
anoth
respiratori
pathogen
result
discontinu
sar
isol
precaut
absenc
appropri
isol
precaut
person
sar
transmit
infect
addit
person
sar
influenza
respiratori
syncyti
viru
communityacquir
pneumonia
primari
caus
death
fri
futur
sar
outbreak
would
manag
use
exist
healthcar
infrastructur
proven
effect
treatment
sar
current
exist
plausibl
rang
high
low
valu
variabl
use
conduct
sensit
analys
examin
influenc
paramet
error
result
analysi
select
variabl
model
list
tabl
use
nation
repres
data
conjunct
studi
publish
medic
literatur
deriv
base
estim
averag
respiratori
season
model
microbiolog
origin
fri
categor
mutual
exclus
group
sarscov
coronavirus
influenza
virus
b
panel
common
respiratori
pathogen
includ
respiratori
syncyti
virus
b
parainfluenza
virus
human
metapneumoviru
bordetella
pertussi
chlamydia
pneumonia
mycoplasma
pneumonia
legionella
pneumophila
l
micdadei
caus
basecas
analysi
assign
proport
fri
due
sar
estim
assum
sar
outbreak
similar
size
durat
toronto
outbreak
proport
fri
due
influenza
deriv
larg
observ
studi
conduct
multipl
respiratori
season
corrobor
divid
expect
proport
us
popul
get
influenza
season
proport
us
popul
influenzalik
infect
proport
fri
due
common
respiratori
pathogen
panel
list
estim
medic
literatur
basecas
scenario
estim
approxim
one
third
fri
would
due
influenza
one
third
would
due
panel
common
respiratori
pathogen
remain
one
third
would
due
miscellan
pathogen
indic
evalu
categori
rapid
diagnost
test
optim
turnaround
time
hour
first
categori
constitut
rtpcr
assay
capabl
detect
sarscov
well
coronavirus
second
categori
includ
multiplex
pcr
assay
use
combin
detect
differ
respiratori
pathogen
includ
influenza
virus
b
respiratori
syncyti
virus
b
parainfluenza
virus
human
metapneumoviru
c
pneumonia
pneumonia
l
pneumophila
l
micdadei
b
pertussi
third
categori
compris
wide
avail
enzym
immunoassay
capabl
rapidli
detect
infect
influenza
b
sensit
specif
test
obtain
medic
literatur
posit
predict
valu
diagnost
test
calcul
incorpor
estim
preval
specif
pathogen
bay
equat
effect
influenza
vaccin
deriv
medic
literatur
account
season
variat
circul
strain
influenza
composit
trival
vaccin
vari
effect
vaccin
wide
rang
plausibl
valu
sensit
analysi
averag
season
effect
influenza
vaccin
adjust
assum
vaccin
would
poorli
match
circul
influenza
strain
approxim
twice
everi
year
use
data
us
behavior
risk
factor
surveil
system
estim
season
influenza
vaccin
rate
among
popul
new
york
citi
sensit
analys
evalu
increment
cost
benefit
rais
vaccin
rate
season
averag
model
home
isol
strategi
requir
person
fri
undetermin
origin
remain
home
least
hour
resolut
ill
assum
adher
public
health
guidelin
set
widespread
sar
outbreak
would
near
univers
strategi
assum
person
would
attempt
manag
ill
home
use
selfcar
visit
healthcar
provid
ill
seriou
persist
proceed
hospit
ill
becam
progress
sever
diagnost
evalu
strategi
involv
outpati
test
person
fri
ascertain
microbiolog
origin
strategi
person
fri
undetermin
caus
would
observ
home
isol
precaut
result
diagnost
test
avail
assum
posit
sar
rtpcr
test
would
requir
isol
precaut
patient
public
health
intervent
addit
test
confirm
diagnosi
also
assum
neg
sar
rtpcr
test
conjunct
posit
test
altern
respiratori
pathogen
would
lead
elimin
isol
precaut
test
result
neg
assum
isol
precaut
would
remain
effect
sinc
current
sar
rtpcr
assay
suffici
sensit
rule
sar
also
assum
person
fri
microbiolog
origin
confirm
due
pathogen
sarscov
would
return
work
resolut
ill
strategi
consid
possibl
person
fri
seek
medic
care
might
receiv
antimicrobi
drug
evalu
estim
probabl
use
data
nation
ambulatori
medic
care
survey
chang
healthrel
qualiti
life
hrql
includ
impact
isol
due
sar
fri
deriv
use
health
util
index
mark
hui
use
hui
minim
doubl
count
product
loss
sinc
hrql
score
gener
instrument
includ
product
loss
william
furlong
per
comm
paramet
hui
deriv
panel
specialist
physician
clinic
experi
manag
sar
patient
toronto
physician
directli
valu
health
state
rather
function
expert
describ
facilit
map
heath
state
communitybas
prefer
score
hui
sar
influenza
respiratori
syncyti
viru
communityacquir
pneumonia
due
typic
atyp
bacteria
assum
primari
contributor
death
fri
popul
level
mortal
data
communityacquir
pneumonia
obtain
nation
center
health
statist
data
sar
influenza
respiratori
syncyti
viru
obtain
medic
literatur
estim
patient
sar
would
transmit
infect
person
appropri
isol
precaut
observ
eg
falseneg
sar
rtpcr
test
combin
falseposit
test
altern
diagnosi
cost
attribut
transport
ambulatori
care
laboratori
test
influenza
vaccin
antimicrobi
agent
hospit
public
health
investig
patient
time
includ
analysi
transport
cost
see
medic
provid
deriv
use
us
nation
data
adjust
account
estim
proport
popul
drive
use
public
transport
travel
mean
bike
walk
base
cost
ambulatori
care
visit
estim
use
nation
averag
medicar
reimburs
rate
focus
medic
evalu
cptcode
cost
rapid
influenza
test
deriv
center
medicar
medicaid
servic
cost
sar
rtpcr
assay
multiplex
pcr
assay
use
detect
common
respiratori
pathogen
panel
obtain
test
manufactur
includ
minut
technician
time
prodess
inc
per
comm
influenza
vaccin
antimicrobi
drug
cost
obtain
use
averag
wholesal
price
pharmaceut
cost
frequenc
advers
reaction
influenza
vaccin
estim
medic
literatur
incorpor
net
cost
benefit
vaccin
hospit
charg
averag
length
stay
patient
influenza
respiratori
infect
requir
hospit
estim
healthcar
cost
util
project
medicar
provid
analysi
review
system
use
deriv
costtocharg
ratio
subsequ
convert
hospit
charg
societ
cost
per
diem
hospit
cost
sar
approxim
use
code
respiratori
distress
syndrom
subsequ
multipli
averag
length
stay
hospit
patient
sar
public
health
cost
includ
contact
investig
estim
toronto
sar
experi
patient
time
cost
estim
data
median
salari
person
live
new
york
citi
includ
time
spent
travel
receiv
medic
care
applic
medic
nonmed
cost
adjust
us
dollar
use
consum
price
index
potenti
econom
effect
sar
outbreak
tourism
commerci
industri
consid
analysi
sar
resurfac
respiratori
season
time
establish
epidemiolog
link
sar
case
possibl
analysi
estim
societ
cost
new
york
citi
would
exceed
billion
month
sar
outbreak
respiratori
season
coincid
basecas
analysi
found
use
multiplex
pcr
assay
detect
infect
broad
panel
common
respiratori
pathogen
domin
strategi
save
million
result
gain
qualityadjust
lifeyear
qali
rel
strategi
home
isol
sar
rtpcr
test
use
conjunct
multiplex
pcr
assay
basecas
scenario
howev
estim
cost
would
increas
million
lower
effect
multiplex
pcr
test
alon
find
directli
relat
low
posit
predict
valu
sar
rtpcr
test
low
preval
condit
harm
result
falseposit
test
result
sar
test
unavail
confirm
altern
diagnosi
fri
would
effect
least
expens
strategi
domin
strategi
influenza
test
alon
home
isol
howev
multiplex
pcr
test
also
unavail
home
isol
would
least
expens
strategi
albeit
less
effect
test
influenza
alon
rapid
influenza
test
would
accomplish
increment
cost
million
would
result
gain
qali
increment
costeffect
ratio
per
qali
gain
describ
outbreak
unfold
campaign
increas
influenza
vaccin
rate
among
gener
popul
onset
respiratori
season
would
save
estim
million
lead
gain
qali
percentag
new
york
citi
popul
vaccin
season
baselin
total
cost
number
qali
gain
increment
costeffect
strategi
model
shown
tabl
result
sensit
analys
shown
tabl
figur
algorithm
outlin
optim
treatment
strategi
differ
test
capabl
shown
figur
analysi
indic
current
diagnost
limit
discrimin
sar
common
fri
could
enorm
public
health
econom
consequ
particularli
epidemiolog
link
sar
case
becom
tenuou
condit
found
cost
would
relat
sar
infect
rather
procedur
chang
manag
fri
due
known
perceiv
presenc
sar
report
key
find
direct
polici
relev
first
base
analysi
effici
mechan
discrimin
sar
infect
fri
involv
exclud
sar
confirm
altern
diagnosi
approach
costeffect
strategi
low
preval
condit
sinc
posit
predict
valu
sar
rtpcr
test
would
extrem
low
falseposit
sar
test
would
deleteri
societ
repercuss
center
diseas
control
prevent
support
approach
exclud
sar
confirm
altern
diagnosi
caution
advis
sinc
sar
coinfect
respiratori
pathogen
includ
human
metapneumoviru
document
second
demonstr
sar
test
low
preval
condit
would
detriment
public
health
econom
perspect
analysi
low
posit
predict
valu
sar
rtpcr
test
translat
unnecessari
cost
diagnost
test
public
health
intervent
lost
opportun
cost
person
falseposit
test
result
moreov
neg
consequ
qualiti
life
would
occur
person
incorrectli
diagnos
infect
sar
sensit
analys
indic
sar
diagnost
test
perform
unless
preval
pretest
probabl
sar
among
person
present
fri
exce
third
use
influenza
vaccin
mean
distinguish
sar
influenza
debat
analysi
find
sar
reemerg
respiratori
season
higher
rate
influenza
vaccin
among
gener
popul
would
lead
health
benefit
econom
save
save
would
occur
reduct
influenza
ill
death
reduct
cost
relat
investig
isol
person
fri
increas
pretest
probabl
sar
therefor
posit
predict
valu
sar
diagnost
test
polici
implic
find
howev
must
care
consid
context
avail
influenza
vaccin
suppli
must
ensur
priorit
group
high
risk
analysi
sever
limit
foremost
inabl
deriv
specif
estim
proport
fri
due
specif
pathogen
sinc
season
composit
respiratori
virus
bacteria
vari
across
region
season
attempt
deriv
estim
best
reflect
season
averag
although
nation
surveil
data
influenza
avail
inform
common
respiratori
pathogen
limit
sinc
pathogen
selflimit
nonreport
diseas
treatment
infrequ
sought
estim
sensit
current
sar
rtpcr
assay
howev
recogn
type
specimen
test
time
collect
influenc
test
sensit
basecas
scenario
sar
repres
circul
fri
chang
sar
rtpcr
test
sensit
neglig
impact
overal
societ
cost
popul
health
pretest
probabl
sar
increas
substanti
baselin
howev
sar
rtpcr
test
sensit
would
increasingli
import
influenc
effect
strategi
involv
sar
test
report
test
sensit
multiplex
pcr
assay
detect
common
respiratori
virus
bacteria
lower
valu
report
medic
literatur
sinc
estim
literatur
reflect
experiment
condit
essenti
measur
test
efficaci
wish
estim
realworld
effect
test
take
account
factor
ineffect
specimen
collect
method
delay
laboratori
test
relat
factor
analysi
demonstr
influenza
vaccin
would
lead
costsav
report
studi
healthi
adult
presar
era
howev
specif
benefit
quantifi
analysi
would
realiz
condit
model
occur
ie
reemerg
sar
respiratori
season
epidemiolog
link
case
poorli
defin
final
analysi
adequ
address
complex
microbiolog
coinfect
develop
fri
model
allow
multipl
posit
test
result
assum
organ
respons
caus
fri
issu
particularli
relev
consid
sar
coinfect
respiratori
organ
nonetheless
analysi
effect
sar
coinfect
popul
level
minim
given
sarscov
infect
make
fri
specul
reemerg
sar
prompt
heighten
surveil
health
offici
worldwid
given
sar
resurfac
past
respiratori
season
absenc
accident
laboratori
exposur
sarscov
may
reappear
annual
time
fri
wide
preval
among
gener
popul
even
world
experi
anoth
largescal
multin
outbreak
healthcar
provid
around
globe
continu
see
patient
nonspecif
fri
incident
return
sarsaffect
area
fact
underscor
import
evidencebas
guidelin
facilit
time
accur
distinct
sar
infect
distinguish
febril
respiratori
ill
sar
fri
lesser
public
health
import
analysi
provid
guidanc
effect
effici
use
resourc
manag
person
fri
undetermin
etiolog
epidemiolog
histori
sar
either
unavail
unreli
find
help
polici
maker
healthcar
practition
make
decis
base
avail
evid
avoid
decis
driven
fear
misinform
